Cite
HARVARD Citation
Alba, M. et al. (n.d.). The effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on mineral metabolism and bone in patients with type 2 diabetes mellitus. Current medical research and opinion. pp. 1375-1385. [Online].